CSI Market
Sign In | Register

Abbott Laboratories (ABT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABT Annual Balance Sheets →
A period-by-period view of the balance sheet from Abbott Laboratories to Mar 31 2025 helps clarify how Mar 31 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent6,803.00
Short-term Investments, Total492.00
Cash & Short-term Investments7,295.00
Accounts receivable8,210.00
Inventories6,989.00
Total Current Assets25,508.00
Equipment/Property/Plant Net25,737.00
Goodwill net35,221.00
Intangible Assets17,875.00
Long-term investments1,090.00
Deferred Income Taxes And Other Assets Noncurrent18,358.00
Inventory Finished Goods Net Of Reserves4,004.00
Inventory Work In Process Net Of Reserves845.00
Inventory Raw Materials Net Of Reserves2,022.00
Prepaid Expense And Other Receivables2,307.00
Total Assets110,429.00
Liabilities
Accounts Payable, Trade, Current4,679.00
Employee-related Liabilities, Current AC1,212.00
Long-term Debt, Current Maturities LO4,409.00
Accrued Income Taxes, Current TA598.00
Total Current Liabilities18,377.00
Long-term debt29,638.00
Total Long-term Debt29,638.00
Employee benefit plans0.00
Deferred income taxes0.00
Post Employment Obligations Deferred Income Taxes And Other Long Term Liabilities7,038.00
Total Liabilities57,728.00
Stockholders' Equity
Treasury Stock Common Value-15,722.00
Common Stock Value25,352.00
Retained Earnings / Accumulated Deficit49,956.00
Accumulated Other Comprehensive Income-6,312.00
Other Equity-6,312.00
Common Stockholder's Equity52,061.00
Non-controlling interests & other640.00
Total Stockholder's Equity52,701.00
Liabilities & Stockholder's Equity110,429.00
4 historic quarters locked

Sign in to unlock the full Abbott Laboratories balance sheet history.

Sign In Create Free Account

About Abbott Laboratories Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 28, 2026
  • Source: abt-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-050134

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.